Maravai Offloads Vector Labs To Private Equity

by Vandana Singh, Benzinga Editor

September 7, 2021 8:01 AM | 23 seconds read | Make a Comment

Thompson Street Capital Partners, a private equity firm, has acquired Vector Laboratories, the Protein Detection business unit of Maravai Lifesciences Holdings Inc MRVI.
The financial terms of the deal were not disclosed.
Vector Laboratories manufactures labeling and visual detection reagents for life science researchers doing tissue-based protein detection and characterization.
Price Action: MRVI shares closed 2.50% lower at $58.61 on Friday.

Posted In: M&A News Health Care Asset Sales General Briefs

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.